Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02863341
Other study ID # 2016/00422
Secondary ID
Status Completed
Phase N/A
First received July 31, 2016
Last updated April 3, 2018
Start date November 2016
Est. completion date April 2018

Study information

Verified date April 2018
Source Tan Tock Seng Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a multi-centre study in Singapore nursing homes, investigating the factors that affecting deprescribing, and if a team-care based deprescribing standard practice gives superior health and pharmacoeconomic outcomes over current medication review practice.


Recruitment information / eligibility

Status Completed
Enrollment 295
Est. completion date April 2018
Est. primary completion date March 2018
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility For interview questionnaire:

Inclusion criteria are:

1. Accepted informed consent,

2. The healthcare professional is practicing in the involved nursing homes.

Exclusion criteria are:

1) Decline/unable to provide consent.

For team-care deprescribing study:

Inclusion criteria are:

1. Accepted informed consent (unless cognitive-impaired, with no or un-contactable next-of-kin),

2. Adult aged 65 years and above,

3. Currently on five or more medications.

Exclusion criteria are:

1. Below the age of 65 years of age,

2. Life expectancy of less than 6 months or respite care.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Team-care deprescribing with deprescribing guide
Beers criteria 2015, STOPP criteria 2014, drug interaction

Locations

Country Name City State
Singapore Nursing homes Singapore

Sponsors (3)

Lead Sponsor Collaborator
Tan Tock Seng Hospital Monash University, National Healthcare Group, Singapore

Country where clinical trial is conducted

Singapore, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in Fall Risk Assessment Tool (FRAT) score Change from baseline in FRAT score at 3 months
Primary Change from baseline in Fall Risk Assessment Tool (FRAT) score Change from baseline in FRAT score at 6 months
Primary Change from baseline in Fall Risk Assessment Tool (FRAT) score Change from baseline in FRAT score at 12 months
Primary Change from baseline in fall rate Change from baseline in fall rate at 3 months
Primary Change from baseline in fall rate Change from baseline in fall rate at 6 months
Primary Change from baseline in fall rate Change from baseline in fall rate at 12 months
Secondary Factors affecting deprescribing Interview questionnaire 0 month
Secondary Change from baseline in mean number of medications per subject Change from baseline in mean number of medications per subject at 3 months
Secondary Change from baseline in mean number of medications per subject Change from baseline in mean number of medications per subject at 6 months
Secondary Change from baseline in mean number of medications per subject Change from baseline in mean number of medications per subject at 12 months
Secondary Change from baseline in mean medication cost per subject Change from baseline in mean medication cost at 3 months
Secondary Change from baseline in mean medication cost per subject Change from baseline in mean medication cost at 6 months
Secondary Change from baseline in mean medication cost per subject Change from baseline in mean medication cost at 12 months
Secondary Change from baseline in deprescribing intervention acceptance rate Change from baseline in deprescribing intervention acceptance rate at 3 months
Secondary Change from baseline in deprescribing intervention acceptance rate Change from baseline in deprescribing intervention acceptance rate at 6 months
Secondary Change from baseline in deprescribing intervention acceptance rate Change from baseline in deprescribing intervention acceptance rate at 12 months
Secondary Change from baseline in percentage of drug-related problems (DRPs) Medication review form (Hepler/Strand DRP classification system) Change from baseline in percentage of DRPs at 3 months
Secondary Change from baseline in percentage of drug-related problems (DRPs) Medication review form (Hepler/Strand DRP classification system) Change from baseline in percentage of DRPs at 6 months
Secondary Change from baseline in percentage of drug-related problems (DRPs) Medication review form (Hepler/Strand DRP classification system) Change from baseline in percentage of DRPs at 12 months
See also
  Status Clinical Trial Phase
Completed NCT02816086 - A New Interdisciplinary Collaboration Structure to Improve Medication Safety in the Elderly N/A
Withdrawn NCT04893395 - Assessment of the Impact of Clinical Pharmacogenomics on Real and Potential Medication Use in Veterans N/A
Completed NCT02562352 - Team Approach to Polypharmacy Evaluation and Reduction N/A
Completed NCT01970774 - Medication Therapy Management With Pharmacogenetic Testing N/A
Completed NCT04151797 - Impact of a Mobile Geriatric Team With a Pharmacist on the Optimisation of Prescriptions in Elderly Inpatients N/A
Enrolling by invitation NCT06383364 - The Effect of a Medication Coordinator on the Quality of Patients Medication Treatment N/A
Completed NCT03154489 - Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care N/A
Completed NCT03257605 - A Pharmacist Implemented Pharmacogenomics Service in the Program of All-inclusive Care for the Elderly N/A
Not yet recruiting NCT06310512 - Efficacy of Pharmacist Interventions Through the "Medication Therapy Management Pathway in Hypertensive Patients" N/A
Recruiting NCT02942927 - Team Approach to Polypharmacy Evaluation and Reduction N/A
Completed NCT03909035 - A Collaborative Approach to Medication Reviews for Older Patients With Polypharmacy N/A
Recruiting NCT03557944 - Team Approach to Polypharmacy Evaluation and Reduction (Pharmacy) N/A
Completed NCT02820129 - Effectiveness of a Medication Wallet Card Phase 1
Terminated NCT03202264 - Team Approach to Polypharmacy Reduction to Improve Mobility Long-Term Care
Completed NCT03321058 - Polymedication-Check With Insight in Patients' Medication Organisation and Comprehension of Generics N/A
Completed NCT02658604 - Home Medication Reviews by Pharmacists in Ontario, Canada N/A
Withdrawn NCT05711771 - Medication Therapy Management (MTM) for a Medicaid Managed Care Population Within Patient-Centered Medical Homes
Recruiting NCT05553015 - A Real-World Registry Investigating TReprostInil sodiUM in Pulmonary Hypertension (Re-TRIUMPH)
Active, not recruiting NCT05278650 - Senior PharmAssist: Co-Design and Evaluation of a Toolkit to Promote Scalable Implementation N/A
Recruiting NCT05351281 - Appropriate Medication Use in Dutch Terminal Care N/A